300760 迈瑞医疗
2026/06 - 中期
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入17,746,9706.00%33,282,15936,725,75034,931,90130,365,644
减:营业总成本12,313,65912.01%23,608,91124,096,44621,991,20519,826,760
    其中:营业成本6,950,8628.30%13,207,83813,547,51912,513,13610,885,289
               财务费用383,022-214.11%(262,908)(400,028)(854,912)(451,037)
               资产减值损失(67,535)-37.78%(335,842)(237,841)(529,506)(71,094)
公允价值变动收益588134.69%486126,02879,402(21,378)
投资收益19,985-80.20%114,95369,390(9,841)(5,061)
    其中:对联营企业和合营企业的投资收益16,199159.04%15,538(11,812)(9,817)(4,698)
营业利润5,566,262-6.01%9,794,89413,111,82413,069,85810,990,515
利润总额5,556,094-6.10%9,673,96613,019,69613,010,93010,953,551
减:所得税费用509,188-25.58%1,222,4941,279,7301,432,5171,342,834
净利润5,046,906-3.55%8,451,47111,739,96711,578,4139,610,717
减:非控股权益250,11452.58%315,69671,479(3,813)3,543
股东净利润4,796,792-5.37%8,135,77511,668,48711,582,2269,607,174

市场价值指针
每股收益 (元) *3.958-5.39%6.7159.6369.5597.940
每股派息 (元) *2.580-5.15%4.3806.2705.8004.500
每股净资产 (元) *33.4503.88%31.41929.57427.28826.377
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容